RxDoctor Payments Data

Krysty Hutto

Family · Bamberg, SCNPI 1033832183

Payments from drug & device makers

$3,397in general payments, 2019–2025

Across 229 payments — averaging $14.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$695
  • Lilly USA, LLC$359
  • Bayer$272
  • Novartis$271
  • AstraZeneca$258
  • Boehringer Ingelheim$213
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,397100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,397 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$91,199
EliquisApixaban52$54,792
JardianceEmpagliflozin43$38,586
FarxigaDapagliflozin Propanediol24$27,773
MounjaroTirzepatide19$19,009
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,855
KerendiaFinerenone17$16,982
RybelsusSemaglutide12$12,831
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,351
JanuviaSitagliptin Phosphate13$10,567
Breo ElliptaFluticasone/Vilanterol14$5,278
Zolpidem Tartrate19$2,898
Rosuvastatin Calcium139$1,870
Megestrol Acetate17$1,602
Sucralfate31$1,499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$168$104,03091 claims
PfizerEliquis$184$54,79252 claims
AstraZenecaFarxiga, Breztri Aerosphere$258$40,12537 claims
Boehringer IngelheimJardiance$213$38,58643 claims
GSKTrelegy Ellipta, Breo Ellipta$133$24,13335 claims
Lilly USA, LLCMounjaro$359$19,00919 claims
BayerKerendia$272$16,98217 claims
MerckJanuvia$20$10,56713 claims
AbbVieSynthroid$695$1,12816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.

Other family in Bamberg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →